Home
About Us
Team
Services
News
Partners
Advisory Board
Contact

News

Oxeia Announces Positive Interim Results of Phase 2 Trial for OXE103 for the Treatment of Concussions
August 3, 2022 0
0
Genetic Engineering & Biotechnology News – Bitter Taste Receptors Represent a Therapeutic Sweet Spot
February 2, 2022 0
0
Aardvark Therapeutics, Inc., Announces the Initiation of Enrollment for Three Phase 2 Clinical Trials Of Oral ARD-101
February 2, 2022 0
0
Oxeia Biopharmaceuticals Announces New Board and Management Team Members and Relocates Corporate Headquarters To Boston
January 20, 2022 0
0
Swiss Gondola Medical Technologies Announces Collaboration with New York’s Mount Sinai Health System to Study Innovative Treatment for Neurological Disorders Such as Parkinson’s Disease
November 3, 2021 0
0

"A creative man merely has ideas; a resourceful man makes them practical." ~ Georges Doriot

42 Front Street
Marblehead, MA 01945
781-631-3117
info@comstratgroup.com

Quick Links

About Us
Team
Services
News
Partners

About Us

The Communications Strategy Group Inc. is a consulting firm offering a full-slate of external communications services to emerging companies in life sciences, biotechnology, health care and advanced technologies.

© The Communications Strategy Group Inc. All rights reserved.

Terms of Use | Privacy Policy